The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
GLP-1 drugs could become personalized for individuals, study says
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!